<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The t(1;19)(q23;p13) translocation occurs commonly in B-lineage ALL </plain></SENT>
<SENT sid="1" pm="."><plain>Previous reports have demonstrated a predominance of cases with expression of cytoplasmic Ig mu (C <z:chebi fb="0" ids="30214">mu+</z:chebi>), and <z:e sem="disease" ids="C0522628" disease_type="Neoplastic Process" abbrv="">FAB L1</z:e>/L2 phenotype, a poor prognosis and expression of a fusion transcript involving the E2A and PBX1 genes in C <z:chebi fb="0" ids="30214">mu+</z:chebi> but not in C mu- cases </plain></SENT>
<SENT sid="2" pm="."><plain>Of 38 patients with karyotypically proven t(1;19) (q23;p13) <z:mpath ids='MPATH_336'>leukaemias</z:mpath>, we extensively analysed 18 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> including 16 B-lineage ALLs, one <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> and one <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> M4 </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> was associated with a classic E2A-PBX1 fusion transcript and may represent the human counterpart of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMLs</z:e> induced by E2A-PBX1 <z:e sem="disease" ids="C0035369" disease_type="Disease or Syndrome" abbrv="">retroviral infection</z:e> of murine marrow progenitors </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> was E2A-PBX1 negative and neither the E2A nor the LYL-1 genes, both situated at chromosome 19 p13, were rearranged </plain></SENT>
<SENT sid="5" pm="."><plain>Of the 16 B-lineage ALLs, four had cytological features resembling an 'L3-like' phenotype classically associated with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, two at diagnosis and relapse and two exclusively at relapse </plain></SENT>
<SENT sid="6" pm="."><plain>E2A-PBX1 fusion transcripts were detected by RT-PCR in <z:hpo ids='HP_0000001'>all</z:hpo> 13 C <z:chebi fb="0" ids="30214">mu+</z:chebi> patients and in 2/3 C mu- cases </plain></SENT>
<SENT sid="7" pm="."><plain>The 'L3-like' phenotype did not correlate with a particular stage of maturation arrest (one sIg+, one C <z:chebi fb="0" ids="30214">mu+</z:chebi>, one C mu-) or type of E2A-PBX1 transcript, but was associated in <z:hpo ids='HP_0000001'>all</z:hpo> cases with a <z:mp ids='MP_0004027'>trisomy</z:mp> 8 </plain></SENT>
<SENT sid="8" pm="."><plain>Translocation, rearrangement, amplification or over-expression of the c-myc gene was not observed in these cases, demonstrating that the apparent association with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 is not due to deregulation of this gene </plain></SENT>
<SENT sid="9" pm="."><plain>We therefore show that the E2A-PBX1 transcript, although occurring predominantly in C <z:chebi fb="0" ids="30214">mu+</z:chebi> <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e>, also occurs in C mu- early <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e>, sIg+ <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> and even in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>These results suggest that the stage of maturation arrest, and indirectly the prognosis, are not solely due to the type of fusion transcript associated with the t(1;19) </plain></SENT>
</text></document>